Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-05
1997-01-07
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514311, 514312, 514313, 514314, 514378, 514379, 546153, 546155, 546159, 546162, 546167, 546172, 548241, 548243, 548244, 548245, 548247, A61K 3142, C07D26110
Patent
active
055917615
ABSTRACT:
Thiophenyl-, furyl- and pyrrolyl-sulfonamides and methods for modulating or altering the activity of the endothelin family of peptides are provided. In particular, isoxazolyl-thiophenyl-sulfonamides, isoxazolyl-furyl-sulfonamides and isoxazolyl-pyrrolyl-sulfonamides and methods using these sulfonamides for inhibiting the binding of an endothelin peptide to an endothelin receptor by contacting the receptor with the sulfonamide are provided. Methods for treating endothelin-mediated disorders by administering effective amounts of one or more of these sulfonamides or prodrugs thereof that inhibit or increase the activity of endothelin are also provided.
REFERENCES:
patent: 3300488 (1967-01-01), Onoue et al.
patent: 3660383 (1972-05-01), Sumimoto et al.
patent: 4752613 (1988-06-01), Floyd et al.
patent: 4997836 (1991-05-01), Sugihara et al.
patent: 5114918 (1992-05-01), Isikawa et al.
patent: 5208243 (1993-05-01), Peglion et al.
patent: 5270313 (1993-12-01), Burri et al.
patent: 5292740 (1994-03-01), Burri et al.
patent: 5378715 (1995-01-01), Stein et al.
patent: 5389620 (1995-02-01), Ishikawa et al.
patent: 5389633 (1995-02-01), Miyake et al.
patent: 5407941 (1995-04-01), Carceller et al.
patent: 5420123 (1995-05-01), Murugesan
patent: 5420129 (1995-05-01), Breu et al.
patent: 5420131 (1995-05-01), Carceller et al.
patent: 5420133 (1995-05-01), Dhanoa et al.
patent: 5420138 (1995-05-01), Corbier et al.
patent: 5420275 (1995-05-01), Masuya et al.
CA 120: 18233n The Discovery. . . -/-naphthalenesulfonamide Stein et al., pp. 21-22, 1994.
Ihara et al., "An endothelin receptor (ET.sub.A) antagonist isolated from Streptomyces Misakiensis", Biochem. and Biophys. Research Commun., 178(1):132-137 (1991).
Spinella et al., "Design and synthesis of a specific endothelin 1 antagonist: Effects on pulmonary vasoconstriction", Proc. Natl. Acad. Sci. USA, 88p:7443-7446 (1991).
Saeki et al.,"[Ala.sup.1,3,11,15 ]endothelin-1 analogs with ET.sub.B agonistic activity", Biochem. and Biophys. Research Commun., 179(1):286-292 (1991).
Gu et al., "The inhibitory effect of [D-Arg.sup.1, D-Phe, D-Try.sup.7,9, Leu.sup.11 ]substance P on endothelin-1 binding sites in rat cardiac membranes", Biochem. and Biophys. Research Commun., 179(1):130-133 (1991).
Panek et al., "Endothelin and structurally related analogs distinguish between endothelin receptor subtypes", Biochem. and Biophys. Research Commun., 183(2):566-571 (1992).
Ihara et al., "Biologicalprofiles of highly potent novel endothelin antagonists selective for the ET.sub.A receptor", Life Sciences, 50:247-255 (1991).
Hirata et al., "Receptor binding activity and cytosolic free calcium response by synthetic endothelin analogs in culture rat vascular smooth muscle cells", Biochem. and Biophys. Research Commun., 160:228-234 (1989).
Nakajima et al., "Synthesis of endothelin-1 analogues, endothelin-3, and sarafotoxin S6b: Structure-activity relationships", J. of Cardiovascular Pharm., 13(Suppl. 5):S8-S12 (1989).
Yanagisawa et al., "A novel potent vasoconstrictor peptide produced by vascular endothelial cells", Nature, 332:411-415 (1988).
Kashiwabara et al., "Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo", FEBS Letters, 247(1):73-76 (1989).
von Geldern et al., "A fluorogenic assay for endothelin-converting enzyme", Peptide Research, 4(1):32-35 (1991).
Inoue et al., "The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes", Proc. Natl. Acad. Sci. USA, 86:2863-2867 (1989).
Saida et al., "A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family", J. Biol. Chem., 264(25):14613-14616 (1989).
Brooks et al., "Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number", Eur. J. of Pharmacology, 194:115-117 (1991).
Bolger et al., "Vascular reactivity, tissue levels, and binding sites for endothelin: A comparison in the spontaneously hypertensive and Wistar-Kyoto rats", Can. J. Physiol. Pharm., 69:406-413 (1990).
Simonson et al., "Endothelin-1 stimulates contraction of rat glomerular mesangial cells and potentiaties .beta.-Adrenergic-mediated cyclic adenosine monophosphate accumulation", J. Clin. Invest., 85:790-797 (1990).
Stewart et al., "Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?" Annals of Internal Medicine, 114(6):464-469 (1991).
Takayanagi et al., "Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation", FEBS Letters, 282(1):103-106 (1991).
Nishikori et al., "Receptor binding affinity and biological activity of C-terminal elongated forms of endothelin-1", Neurochem. Int., 18(4):535-539 (1991).
Castiglione et al., "Alanine scan of endothelin", Peptides: Chemistry and Biology, Proc. Amer. Rept. Symp. (Twelfth), J. A. Smith and J. E. Rivier, Eds. ESCOM, Leiden, 1992, pp. 402-403.
Galantino et al., "D-Amino acid scan of endothelin", Peptides: Chemistry & Biology, Proc. Amer. Report. Symp. (Twelfth), J. A. Smith and J. E. Rivier, Eds., ESCOM, Leiden, 1992, pp. 404-405.
Filep et al., "Endothelin-1 induces prostacyclin release from bovine aortic endothelial cells", Biochem. and Biophys. Research Comm., 177(1):171-176 (1991).
Spokes et al., "Studies with endothelin-3 and endothelin-1 on rat blood pressure and isolated tissues: Evidence for multiple endothelin receptor subtypes", J. of Cardiovascular Pharmacology, 13(Suppl. 5):S191-S192 (1989).
Cardell et al., "Two functional endothelin receptors in guinea-pig pulmonary arteries", Neurochem. Int., 18(4):571-574 (1991).
Borges et al., "Tissue selectivity of endothelin", Eur. J. of Pharmacology, 165:223-230 (1989).
Ogawa et al., "Molecular cloning of a non-isopeptide-selective human endothelin receptor", Biochem. and Biophys. Research Comm., 178(1):248-255 (1991).
Schvartz et al., "Bovine cerebellum endothelin receptor: Solubilization and identification", Endocrinology, 126(6):3218-3222 (1990).
Saudek et al., "Solution conformation of endothelin-1 by .sup.1 H NMR, CD, and molecular modeling", Int. J. Peptide Protein Res., 37:174-179 (1991).
Aumelas et al., "Determination of the structure of [Nle.sup.7 ]-endothelin by .sup.1 H NMR", Int. J. Peptide Protein Res., 37:315-324 (1991).
Perkins et al., "Proposed solution structure of endothelin", Int. J. Peptide Protein Res., 36:128-133 (1990).
Spinella et al., "A proposed structural model of endothelin", Peptide Research, 2(4):286-291 (1989).
Saudek et al., ".sup.1 H-NMR study of endothelin, sequence-specific assignment of the spectrum and a solution structure", FEBS Letters, 257(1):145-148 (1989).
Ramachandran et al., "Conformation of polypeptides and proteins", Adv. Prot. Chem., 23:283-437 (1968).
Szelke et al., "Novel transition-state analogue inhibitors of renin", In Peptides: Structure and Function, Proceeding of the Eighth American peptide symposium, (Hruby and Rich, Eds.); pp. 579-582, Pierce Chemical Co., Rockford, Illinois (1983).
Allen et al., "The Cambridge crystallographic data centre: Computer-based search, retrieval, analysis and display of Information", Acta Crystallogr., B35:2331-2339 (1979).
Weiner et al., "A new force field for molecular mechanical simulation of nucleic acids and proteins", J. Am. Chem. Soc., 106(3):765-784 (Eng.) (1984).
Cooper et al., "A novel approach to molecular similarity", J. Comput.-Aided Mol. Design, 3:253-259 (1989).
Brint et al., "Upperbound procedures for the identification of similar three-dimensional chemical structures", J. Comput.-Aided Mol. Design, 2:311-310 (1988).
Weiner et al., "An all atom force field for simulations of proteins and nucleic acids", J. Comput. Chem., 7(2):230-252 (1986).
Karplus, M., "Molecular Dynamics: Applications to Proteins", in Computer Simulation of Chemical and Biomolecular Systems, (Bevendge and Jorfensen, Eds. ) Annals of the New York Acad. Science, 482:255-266 (1986).
Balasubramanian, R., "New type of representation for mapping chain folding in protein molecules", Natu
Balaji Vitukudi N.
Castillo Rosario S.
Chan Ming F.
Kois Adam
Raju Bore G.
McKane Joseph K.
Seidman Stephanie L.
Texas Biotechnology Corporation
LandOfFree
Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764607